Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals

Diel Roland, Nienhaus Albert, Hillemann Doris, Richter Elvira

Source: Eur Respir J 2016; 47: 575-587
Journal Issue: February
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Diel Roland, Nienhaus Albert, Hillemann Doris, Richter Elvira. Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals. Eur Respir J 2016; 47: 575-587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe
Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018
Year: 2018



How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
Source: Eur Respir J 2015; 45: 549-554
Year: 2015


Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India
Source: Eur Respir J 2014; 44: 1090-1093
Year: 2014


Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012


Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012



A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


MDR-TB treatment efficacy by results of Xpert MTB/RIF assayin the Stavropol region of the Russian Federation
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018


Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda
Source: International Congress 2017 – Update on TB: latest news
Year: 2017



A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019



Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012



Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020


Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021